AUTHORS
Emmanuella Dwomo Agyei, Michelle M Castillo, PhD2, Kirkwood A Pritchard Jr, PhD3, Rashmi Sood, PhD4
AFFILIATIONS
1 Medical College of Wisconsin, Milwaukee, Wisconsin, United States
2 Medical College of Wisconsin, Milwaukee, Wisconsin, United States
3 Children's Research Institute, Milwaukee, Wisconsin, United States, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
4 Children's Research Institute, Milwaukee, Wisconsin, United States, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
ABSTRACT
Background: Placental abruption is a life-threatening hemorrhagic pregnancy complication where the placenta partially separates from the uterus before delivery. Histological and epidemiological evidence suggest association with maternal thrombophilia and inflammation, but the cellular mechanisms linking dysregulated coagulation to tissue injury and abruption remain poorly defined. We have demonstrated that mice deficient in Endothelial Protein C Receptor (EPCR), an endogenous inhibitor of blood coagulation, develop placental abruption. The uteri of these mice show presence of decidual blood clots, neutrophil infiltration, and localized release of myeloperoxidase (MPO) (PMID 33158859). EPCR-deficient mice additionally show Bronchus-associated lymphoid tissue (BALT) development and lung injury that worsens with advancing gestation. EPCR is expressed by endothelial, hematopoietic, and trophoblast cells. In humans, inflammation or infection induces EPCR shedding, causing loss of membrane EPCR and localized impairment of its function. Increased soluble EPCR in plasma and the presence of EPCR autoantibodies are associated with fetal death. It remains unclear which EPCR-expressing compartment protects against placental and pulmonary pathologies and the extent to which neutrophils drive pathology. We used neutrophil-depletion to determine whether neutrophils drive placental and lung pathology in globally EPCR-deficient mice and genetic approach to determine whether endothelial-specific EPCR loss is sufficient to reproduce both phenotypes.
Methods: EPCR-deficient dams were mated to wild type (WT) males. Neutrophils were depleted with anti-Ly6G antibodies at gestation days (GD) 6.5 and 9.5, and depletion was confirmed by flow cytometry. Pregnancies were monitored from early gestation for signs of vaginal bleeding and analyzed at GD 12.5. Uteri and lungs were collected for histological, immunohistochemical, qPCR and western blot analyses. Lung analysis included measurements of septal density and mean linear intercept on coronal sections. To examine the role of endothelial EPCR loss on placental and lung pathologies, Tie2-Cre EPCRfl/fl mice were generated, and females were mated with WT males for pregnancy analysis.
Results: Anti-Ly6G treatment depleted circulating neutrophils and significantly reduced neutrophils within decidual clots (~ 6-fold reduction; p=0.013). Total uteroplacental MPO protein was restored to WT levels, confirming marked suppression of the neutrophil/MPO axis. Neutrophil depletion also reduced Cxcl2 expression compared to untreated EPCR-deficient uteri. Nevertheless, EPCR-deficient dams continued to exhibit uterine bleeding and histologic features of placental abruption. Because incomplete or biologically ineffective depletion could obscure a neutrophil contribution, we evaluated maternal lung injury as an independent measure of the functional effect of neutrophil depletion. In contrast to persistent placental pathology, no BALTs were observed in the lungs of EPCR-deficient mice treated with neutrophil depleting antibodies. In addition, pregnancy-associated progression of lung injury was ameliorated in neutrophil-depleted EPCR-deficient mice, demonstrating a biologically effective response.
We next examined whether loss of endothelial EPCR is sufficient to reproduce placental and lung pathologies. Lungs of Tie2-Cre EPCRfl/fl mice did not exhibit BALTs but pregnant females reproduced decidual thrombosis associated with uterine hemorrhage, the hallmarks of placental abruption. Although BALTs were absent in the lungs of non-pregnant endothelial-specific EPCR-deficient mice, they appeared in 3 of 9 pregnancies at GD12.5. Morphometric analysis of lungs in the endothelial-specific EPCR-deficient model is still in progress.
Conclusion: Neutrophils and NETosis-associated products have been implicated as mediators of thrombotic and placental injuries. By depleting neutrophils, we have shown that they are indeed involved in MPO release and inflammation in EPCR-deficient decidua but do not play a key role in mediating thrombophilia-associated placental abruption. We further conclude that loss of EPCR from the endothelium is sufficient to reproduce placental abruption observed with global EPCR deficiency. Taken together, endothelial loss of EPCR is positioned as the upstream driver of placental abruption, while neutrophil accumulation is a consequential and modulatory response rather than the central cause.
DISCLOSURES
Rashmi Sood, PhD: No relevant conflicts of interest to declare.